The plausibility of maternal toxicant exposure and nutritional status as contributing factors to the risk of autism spectrum disorders

References

• Weintraub K. The prevalence puzzle: autism counts. Nature 2011;479(7371):22–4. doi: 10.1038/479022a
   PubMed Web of Science ®Google Scholar
• Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012;5(3):160–79. doi: 10.1002/aur.239
   PubMed Web of Science ®Google Scholar
• Lundstrom S, Reichenberg A, Anckarsater H, Lichtenstein P, Gillberg C. Autism phenotype versus registered diagnosis in Swedish children: prevalence trends over 10 years in general population samples. BMJ 2015;350:h1961. doi: 10.1136/bmj.h1961
   Google Scholar
• Hansen SN, Schendel DE, Parner ET. Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. JAMA Pediatr 2015;169(1):56–62. doi: 10.1001/jamapediatrics.2014.1893
   PubMed Web of Science ®Google Scholar
• Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68(11):1095–102. doi: 10.1001/archgenpsychiatry.2011.76
   PubMed Web of Science ®Google Scholar
• Lee BK, Magnusson C, Gardner RM, Blomstrom A, Newschaffer CJ, Burstyn I, et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun 2015;44:100–5. doi: 10.1016/j.bbi.2014.09.001
   PubMed Web of Science ®Google Scholar
• Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA. Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord 2013. doi: 10.1007/s10803-013-2016-3.
   PubMed Web of Science ®Google Scholar
• Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010;40(12):1423–30. doi: 10.1007/s10803-010-1006-y
   PubMed Web of Science ®Google Scholar
• Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2014;19(2):259–64. doi: 10.1038/mp.2012.197
   PubMed Web of Science ®Google Scholar
• Ehninger D, Sano Y, de Vries PJ, Dies K, Franz D, Geschwind DH, et al. Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry 2012;17(1):62–70. doi: 10.1038/mp.2010.115
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 2012;96(1):80–9. doi: 10.3945/ajcn.110.004416
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Tancredi DJ, Krakowiak P, Hansen RL, Ozonoff S. Maternal intake of supplemental iron and risk of autism spectrum disorder. Am J Epidemiol 2014;180(9):890–900. doi: 10.1093/aje/kwu208
   PubMed Web of Science ®Google Scholar
• Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL, et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012;129(5):e1121–8. doi: 10.1542/peds.2011-2583
   PubMed Web of Science ®Google Scholar
• Reynolds LC, Inder TE, Neil JJ, Pineda RG, Rogers CE. Maternal obesity and increased risk for autism and developmental delay among very preterm infants. J Perinatol 2014;34(9):688–92. doi: 10.1038/jp.2014.80
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2012;17(4):389–401. doi: 10.1038/mp.2011.165
   PubMed Web of Science ®Google Scholar
• Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001;43(3):202–6. doi: 10.1111/j.1469-8749.2001.tb00188.x
   PubMed Web of Science ®Google Scholar
• Bromley RL, Mawer G, Clayton-Smith J, Baker GA, Liverpool, Manchester Neurodevelopment G. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008;71(23):1923–4. doi: 10.1212/01.wnl.0000339399.64213.1a
   PubMed Web of Science ®Google Scholar
• Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007;115(10):1482–9.
   PubMed Web of Science ®Google Scholar
• Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009;195(1):7–14. doi: 10.1192/bjp.bp.108.051672
   PubMed Web of Science ®Google Scholar
• Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996;370(2):247–61. doi: 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Patterson PH. Maternal infection and immune involvement in autism. Trends Mol Med 2011;17(7):389–94. doi: 10.1016/j.molmed.2011.03.001
   PubMed Web of Science ®Google Scholar
• Ashwood P, Schauer J, Pessah IN, Van de Water J. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol 2009;208(1–2):130–5. doi: 10.1016/j.jneuroim.2008.12.012
   PubMed Web of Science ®Google Scholar
• Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol 2013;36:67–81. doi: 10.1016/j.ntt.2012.07.006
   PubMed Web of Science ®Google Scholar
• Grabrucker AM. Environmental factors in autism. Front Psychiatry 2012;3:118.
   PubMedGoogle Scholar
• Velie EM, Block G, Shaw GM, Samuels SJ, Schaffer DM, Kulldorff M. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol 1999;150(6):605–16. doi: 10.1093/oxfordjournals.aje.a010059
   PubMed Web of Science ®Google Scholar
• Chowanadisai W, Graham DM, Keen CL, Rucker RB, Messerli MA. Neurulation and neurite extension require the zinc transporter ZIP12 (slc39a12). Proc Natl Acad Sci USA 2013;110(24):9903–8. doi: 10.1073/pnas.1222142110
   PubMed Web of Science ®Google Scholar
• Yasuda H, Yoshida K, Yasuda Y, Tsutsui T. Infantile zinc deficiency: association with autism spectrum disorders. Sci Rep 2011;1:129. doi: 10.1038/srep00129
   PubMed Web of Science ®Google Scholar
• Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. PloS One 2012;7(11):e50568. doi: 10.1371/journal.pone.0050568
   PubMed Web of Science ®Google Scholar
• Nuttall JR, Oteiza PI. Zinc and the ERK kinases in the developing brain. Neurotox Res 2012;21(1):128–41. doi: 10.1007/s12640-011-9291-6
   PubMed Web of Science ®Google Scholar
• Nuttall JR, Supasai S, Kha J, Vaeth BM, Mackenzie GG, Adamo AM, et al. Gestational marginal zinc deficiency impaired fetal neural progenitor cell proliferation by disrupting the ERK1/2 signaling pathway. J Nutr Biochem 2015; 26(11):1116–23. doi: 10.1016/j.jnutbio.2015.05.007
   PubMed Web of Science ®Google Scholar
• Grabrucker S, Jannetti L, Eckert M, Gaub S, Chhabra R, Pfaender S, et al. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. Brain 2014;137(Pt 1):137–52. doi: 10.1093/brain/awt303
   PubMed Web of Science ®Google Scholar
• Russo AJ, Devito R. Analysis of copper and zinc plasma concentration and the efficacy of zinc therapy in individuals with Asperger's syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS) and autism. Biomark Insights 2011;6:127–33. doi: 10.4137/BMI.S7286
   PubMedGoogle Scholar
• Li SO, Wang JL, Bjorklund G, Zhao WN, Yin CH. Serum copper and zinc levels in individuals with autism spectrum disorders. Neuroreport 2014;25(15):1216–20. doi: 10.1097/WNR.0000000000000251
   PubMed Web of Science ®Google Scholar
• Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci 2004;75(21):2539–49. doi: 10.1016/j.lfs.2004.04.038
   PubMed Web of Science ®Google Scholar
• Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011;70(5):886–97. doi: 10.1016/j.neuron.2011.05.015
   PubMed Web of Science ®Google Scholar
• Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369(9559):397–408. doi: 10.1016/S0140-6736(07)60196-2
   PubMed Web of Science ®Google Scholar
• Baecker T, Mangus K, Pfaender S, Chhabra R, Boeckers TM, Grabrucker AM. Loss of COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated pathway at glutamatergic synapses. Biometals 2014;27(4):715–30. doi: 10.1007/s10534-014-9764-1
   PubMed Web of Science ®Google Scholar
• Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007;56(1):115–20. doi: 10.1136/gut.2005.087262
   PubMed Web of Science ®Google Scholar
• Brewer GJ, Dick RD, Johnson VD, Fink JK, Kluin KJ, Daniels S. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001;137(3):191–8. doi: 10.1067/mlc.2001.113037
   PubMed Web of Science ®Google Scholar
• Brewer GJ. Zinc therapy induction of intestinal metallothionein in Wilson's disease. Am J Gastroenterol 1999;94(2):301–2. doi: 10.1111/j.1572-0241.1999.00301.x
   PubMed Web of Science ®Google Scholar
• Johnson S. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med Hypotheses 2001;56(5):641–5. doi: 10.1054/mehy.2000.1302
   PubMed Web of Science ®Google Scholar
• Walker LR, Rattigan M, Canterino J. A case of isolated elevated copper levels during pregnancy. J Pregnancy 2011;2011:385767. doi: 10.1155/2011/385767
   PubMedGoogle Scholar
• Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy. J Pregnancy. 2012;2012:630519. doi: 10.1155/2012/630519
   PubMedGoogle Scholar
• Chang S, Zeng L, Brouwer ID, Kok FJ, Yan H. Effect of iron deficiency anemia in pregnancy on child mental development in rural China. Pediatrics 2013;131(3):e755–63. doi: 10.1542/peds.2011-3513
   PubMed Web of Science ®Google Scholar
• Golub MS, Hogrefe CE. Fetal iron deficiency and genotype influence emotionality in infant rhesus monkeys. J Nutr 2015;145(3):647–53. doi: 10.3945/jn.114.201798
   PubMed Web of Science ®Google Scholar
• Tamura T, Goldenberg RL, Hou J, Johnston KE, Cliver SP, Ramey SL, et al. Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. J Pediatr 2002;140(2):165–70. doi: 10.1067/mpd.2002.120688
   PubMed Web of Science ®Google Scholar
• De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010;(10):CD007950. doi: 10.1002/14651858.CD007950.pub2.
   Google Scholar
• Suren P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 2013;309(6):570–7. doi: 10.1001/jama.2012.155925
   PubMed Web of Science ®Google Scholar
• Berry RJ, Crider KS, Yeargin-Allsopp M. Periconceptional folic acid and risk of autism spectrum disorders. JAMA 2013;309(6):611–3. doi: 10.1001/jama.2013.198
   PubMed Web of Science ®Google Scholar
• Schmidt RJ. Maternal folic acid supplements associated with reduced autism risk in the child. Evid Based Med 2013;18(6):e53. doi: 10.1136/eb-2013-101311
   Google Scholar
• Faucher MA. Folic acid supplementation before and in early pregnancy may decrease risk for autism. J Midwifery Women's Health 2013;58(4):471–2. doi: 10.1111/jmwh.12081_1
   PubMedGoogle Scholar
• Yan L, Zhao L, Long Y, Zou P, Ji G, Gu A, et al. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PloS One 2012;7(10):e41689. doi: 10.1371/journal.pone.0041689
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ, et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 2011;22(4):476–85. doi: 10.1097/EDE.0b013e31821d0e30
   PubMed Web of Science ®Google Scholar
• Divyya S, Naushad SM, Addlagatta A, Murthy PV, Reddy ChR, Digumarti RR, et al. Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility. Gene 2012;497(2):273–9. doi: 10.1016/j.gene.2012.01.055
   PubMed Web of Science ®Google Scholar
• Schaevitz LR, Picker JD, Rana J, Kolodny NH, Shane B, Berger-Sweeney JE, et al. Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders. Dev Neurobiol 2012;72(6):891–905. doi: 10.1002/dneu.21000
   PubMed Web of Science ®Google Scholar
• Bentley TG, Weinstein MC, Willett WC, Kuntz KM. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr 2009;12(4):455–67. doi: 10.1017/S1368980008002565
   PubMed Web of Science ®Google Scholar
• Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 2009;106(36):15424–9. doi: 10.1073/pnas.0902072106
   PubMed Web of Science ®Google Scholar
• Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997;65(6):1790–5.
   PubMed Web of Science ®Google Scholar
• Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, et al. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am J Clin Nutr 2010;92(2):383–9. doi: 10.3945/ajcn.2010.29499
   PubMed Web of Science ®Google Scholar
• Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health 2007;7:41. doi: 10.1186/1471-2458-7-41
   PubMed Web of Science ®Google Scholar
• Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci Lett 2007;422(1):24–9. doi: 10.1016/j.neulet.2007.05.025
   PubMed Web of Science ®Google Scholar
• Board. NAoSIoMFaN. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin b6, folate, vitamin b12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.
   Google Scholar
• Keen CL, Uriu-Adams JY, Skalny A, Grabeklis A, Grabeklis S, Green K, et al. The plausibility of maternal nutritional status being a contributing factor to the risk for fetal alcohol spectrum disorders: the potential influence of zinc status as an example. BioFactors 2010;36(2):125–35.
   PubMed Web of Science ®Google Scholar
• Ramadori G, Van Damme J, Rieder H, Meyer zum Buschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 1988;18(8):1259–64. doi: 10.1002/eji.1830180817
   PubMed Web of Science ®Google Scholar
• Qin L, He J, Hanes RN, Pluzarev O, Hong JS, Crews FT. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 2008;5:10. doi: 10.1186/1742-2094-5-10
   PubMed Web of Science ®Google Scholar
• Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA 2005;102(19):6843–8. doi: 10.1073/pnas.0502257102
   PubMed Web of Science ®Google Scholar
• Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. CMLS 2002;59(4):627–47. doi: 10.1007/s00018-002-8454-2
   PubMed Web of Science ®Google Scholar
• Philcox JC, Coyle P, Michalska A, Choo KH, Rofe AM. Endotoxin-induced inflammation does not cause hepatic zinc accumulation in mice lacking metallothionein gene expression. Biochem J 1995;308(Pt 2):543–6. doi: 10.1042/bj3080543
   PubMed Web of Science ®Google Scholar
• Chua JS, Rofe AM, Coyle P. Dietary zinc supplementation ameliorates LPS-induced teratogenicity in mice. Pediatr Res 2006;59(3):355–8. doi: 10.1203/01.pdr.0000199906.37619.9c
   PubMed Web of Science ®Google Scholar
• Coyle P, Tran N, Fung JN, Summers BL, Rofe AM. Maternal dietary zinc supplementation prevents aberrant behaviour in an object recognition task in mice offspring exposed to LPS in early pregnancy. Behav Brain Res 2009;197(1):210–8. doi: 10.1016/j.bbr.2008.08.022
   PubMed Web of Science ®Google Scholar
• Carey LC, Berbee PL, Coyle P, Philcox JC, Rofe AM. Zinc treatment prevents lipopolysaccharide-induced teratogenicity in mice. Birth Defects Res A Clin Mol Teratol 2003;67(4):240–5. doi: 10.1002/bdra.10035
   PubMed Web of Science ®Google Scholar
• Kirsten TB, Queiroz-Hazarbassanov N, Bernardi MM, Felicio LF. Prenatal zinc prevents communication impairments and BDNF disturbance in a rat model of autism induced by prenatal lipopolysaccharide exposure. Life Sci 2015;130:12–7. doi: 10.1016/j.lfs.2015.02.027
   PubMed Web of Science ®Google Scholar
• Leazer TM, Daston GP, Keen CL, Rogers JM. The embryolethality of lipopolysaccharide in CD-1 and metallothionein I-II null mice: lack of a role for induced zinc deficiency or metallothionein induction. Toxicol Sci 2003;73(2):442–7. doi: 10.1093/toxsci/kfg088
   PubMed Web of Science ®Google Scholar
• Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271–6. doi: 10.1172/JCI200420945
   PubMed Web of Science ®Google Scholar
• Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106(5):1864–6. doi: 10.1182/blood-2005-03-1159
   PubMed Web of Science ®Google Scholar
• Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes 2007;31(9):1412–9. doi: 10.1038/sj.ijo.0803625
   PubMed Web of Science ®Google Scholar
• Kim H, Hwang JY, Ha EH, Park H, Ha M, Lee SJ, et al. Association of maternal folate nutrition and serum C-reactive protein concentrations with gestational age at delivery. Eur J Clin Nutr 2011;65(3):350–6. doi: 10.1038/ejcn.2010.267
   PubMed Web of Science ®Google Scholar
• Zhao M, Chen YH, Chen X, Dong XT, Zhou J, Wang H, et al. Folic acid supplementation during pregnancy protects against lipopolysaccharide-induced neural tube defects in mice. Toxicol Lett 2014;224(2):201–8. doi: 10.1016/j.toxlet.2013.10.021
   PubMed Web of Science ®Google Scholar
• Christian LM, Porter K. Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine 2014;70(2):134–40. doi: 10.1016/j.cyto.2014.06.018
   PubMed Web of Science ®Google Scholar
• Sanders TR, Kim DW, Glendining KA, Jasoni CL. Maternal obesity and IL-6 lead to aberrant developmental gene expression and deregulated neurite growth in the fetal arcuate nucleus. Endocrinology 2014;155(7):2566–77. doi: 10.1210/en.2013-1968
   PubMed Web of Science ®Google Scholar
• Sen S, Iyer C, Meydani SN. Obesity during pregnancy alters maternal oxidant balance and micronutrient status. J Perinatol 2014;34(2):105–11. doi: 10.1038/jp.2013.153
   PubMed Web of Science ®Google Scholar
• Phillips AK, Roy SC, Lundberg R, Guilbert TW, Auger AP, Blohowiak SE, et al. Neonatal iron status is impaired by maternal obesity and excessive weight gain during pregnancy. J Perinatol 2014;34(7):513–8. doi: 10.1038/jp.2014.42
   PubMed Web of Science ®Google Scholar
• Dao MC, Sen S, Iyer C, Klebenov D, Meydani SN. Obesity during pregnancy and fetal iron status: is hepcidin the link? J Perinatol 2013;33(3):177–81. doi: 10.1038/jp.2012.81
   PubMed Web of Science ®Google Scholar
• da Silva VR, Hausman DB, Kauwell GP, Sokolow A, Tackett RL, Rathbun SL, et al. Obesity affects short-term folate pharmacokinetics in women of childbearing age. Int J Obes 2013;37(12):1608–10. doi: 10.1038/ijo.2013.41
   PubMed Web of Science ®Google Scholar
• Garcia-Valdes L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda MT, et al. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Int J Obes 2015;39(4):571–8. doi: 10.1038/ijo.2015.3
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008;198(6):611–9. doi: 10.1016/j.ajog.2008.04.021
   PubMed Web of Science ®Google Scholar
• Khakzad MR, Javanbakht M, Shayegan MR, Kianoush S, Omid F, Hojati M, et al. The complementary role of high sensitivity C-reactive protein in the diagnosis and severity assessment of autism. Res Autism Spectr Disord 2012;6(3):1032–7. doi: 10.1016/j.rasd.2011.10.002
   Web of Science ®Google Scholar
• Leibowitz KL, Moore RH, Ahima RS, Stunkard AJ, Stallings VA, Berkowitz RI, et al. Maternal obesity associated with inflammation in their children. World J Pediatr 2012;8(1):76–9. doi: 10.1007/s12519-011-0292-6
   PubMed Web of Science ®Google Scholar
• Hsiao EY, McBride SW, Chow J, Mazmanian SK, Patterson PH. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci USA 2012;109(31):12776–81. doi: 10.1073/pnas.1202556109
   PubMed Web of Science ®Google Scholar
• Wong CP, Rinaldi NA, Ho E. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. Mol Nutr Food Res 2015;59(5):991–9. doi: 10.1002/mnfr.201400761
   PubMed Web of Science ®Google Scholar
• Kurita H, Ohsako S, Hashimoto S, Yoshinaga J, Tohyama C. Prenatal zinc deficiency-dependent epigenetic alterations of mouse metallothionein-2 gene. J Nutr Biochem 2013;24(1):256–66. doi: 10.1016/j.jnutbio.2012.05.013
   PubMed Web of Science ®Google Scholar
• Vruwink KG, Hurley LS, Gershwin ME, Keen CL. Gestational zinc deficiency amplifies the regulation of metallothionein induction in adult mice. Proc Soc Exp Biol Med 1988;188(1):30–4. doi: 10.3181/00379727-188-42702
   PubMed Web of Science ®Google Scholar
• Haase H, Rink L. Zinc signals and immune function. Biofactors 2013;40(1):27–40. doi: 10.1002/biof.1114
   PubMed Web of Science ®Google Scholar
• Beach RS, Gershwin ME, Hurley LS. Gestational zinc deprivation in mice: persistence of immunodeficiency for three generations. Science 1982;218(4571):469–71. doi: 10.1126/science.7123244
   PubMed Web of Science ®Google Scholar
• Mikael LG, Pancer J, Jiang X, Wu Q, Caudill M, Rozen R. Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-gamma in spleen and placenta, and through reduction of methylation potential. Mol Nutr Food Res 2013;57(4):661–70. doi: 10.1002/mnfr.201200152
   PubMed Web of Science ®Google Scholar
• Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry 2013;18(3):369–81. doi: 10.1038/mp.2011.175
   PubMed Web of Science ®Google Scholar
• Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care 2014;44(10):277–318. doi: 10.1016/j.cppeds.2014.06.001
   PubMed Web of Science ®Google Scholar
• Stevens SA, Nash K, Koren G, Rovet J. Autism characteristics in children with fetal alcohol spectrum disorders. Child Neuropsychol 2013;19(6):579–87. doi: 10.1080/09297049.2012.727791
   PubMed Web of Science ®Google Scholar
• Nanson JL. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 1992;16(3):558–65. doi: 10.1111/j.1530-0277.1992.tb01417.x
   PubMed Web of Science ®Google Scholar
• Bui LM, Taubeneck MW, Commisso JF, Uriu-Hare JY, Faber WD, Keen CL. Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid. Toxicology 1998;126(1):9–21. doi: 10.1016/S0300-483X(97)00171-6
   PubMed Web of Science ®Google Scholar
• Kwong WT, Friello P, Semba RD. Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis. Sci Total Environ 2004;330(1–3):21–37. doi: 10.1016/j.scitotenv.2004.03.017
   PubMed Web of Science ®Google Scholar
• Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. New England J Med 2010;362(23):2185–93. doi: 10.1056/NEJMoa0907328
   PubMed Web of Science ®Google Scholar
• Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, et al. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008;33(6):728–40. doi: 10.1016/j.psyneuen.2008.02.011
   PubMed Web of Science ®Google Scholar
• Padmanabhan R, Shafiullah MM. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Congenit Anom 2003;43(1):29–40. doi: 10.1111/j.1741-4520.2003.tb01024.x
   PubMedGoogle Scholar
• Elmazar MM, Thiel R, Nau H. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. Fundam Appl Toxicol 1992;18(3):389–94. doi: 10.1016/0272-0590(92)90137-7
   PubMedGoogle Scholar
• Hansen DK, Grafton TF, Dial SL, Gehring TA, Siitonen PH. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo. Teratology 1995;52(5):277–85. doi: 10.1002/tera.1420520506
   PubMedGoogle Scholar
• Jin J, Xiong T, Hou X, Sun X, Liao J, Huang Z, et al. Role of Nrf2 activation and NF-kappaB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice. Food Chem Toxicol 2014;73:95–104. doi: 10.1016/j.fct.2014.08.009
   PubMed Web of Science ®Google Scholar
• Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal 2006;26(3):803–24. doi: 10.1111/j.1539-6924.2006.00770.x
   PubMed Web of Science ®Google Scholar
• Testa C, Nuti F, Hayek J, De Felice C, Chelli M, Rovero P, et al. Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro 2012;4(4):223–9. doi: 10.1042/AN20120015
   PubMed Web of Science ®Google Scholar
• Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of age. Neurotoxicology 2009;30(5):822–31. doi: 10.1016/j.neuro.2009.01.011
   PubMed Web of Science ®Google Scholar
• Dai Y, Yang Y, Xu X, Hu Y. Effects of uterine and lactational exposure to di-(2-ethylhexyl) phthalate on spatial memory and NMDA receptor of hippocampus in mice. Horm Behav 2015;71:41–8. doi: 10.1016/j.yhbeh.2015.03.008
   PubMed Web of Science ®Google Scholar
• Lee KI, Chiang CW, Lin HC, Zhao JF, Li CT, Shyue SK, et al. Maternal exposure to di-(2-ethylhexyl) phthalate exposure deregulates blood pressure, adiposity, cholesterol metabolism and social interaction in mouse offspring. Arch Toxicol 2015. doi: 10.1007/s00204-015-1539-0.
   Web of Science ®Google Scholar
• Werling DM, Geschwind DH. Understanding sex bias in autism spectrum disorder. Proc Natl Acad Sci USA 2013;110(13):4868–9. doi: 10.1073/pnas.1301602110
   PubMed Web of Science ®Google Scholar
• Eikel D, Lampen A, Nau H. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chem Res Toxicol 2006;19(2):272–8. doi: 10.1021/tx0502241
   PubMed Web of Science ®Google Scholar
• Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004;64(3):1079–86. doi: 10.1158/0008-5472.CAN-03-0799
   PubMed Web of Science ®Google Scholar
• Lee J, Park J, Jang B, Knudsen TB. Altered expression of genes related to zinc homeostasis in early mouse embryos exposed to di-2-ethylhexyl phthalate. Toxicol Lett 2004;152(1):1–10. doi: 10.1016/j.toxlet.2004.03.011
   PubMed Web of Science ®Google Scholar
• Peters JM, Taubeneck MW, Keen CL, Gonzalez FJ. Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha. Teratology 1997;56(5):311–6. doi: 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-#
   PubMedGoogle Scholar
• Nishioka J, Iwahara C, Kawasaki M, Yoshizaki F, Nakayama H, Takamori K, et al. Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages. Inflamm Res 2012;61(1):69–78. doi: 10.1007/s00011-011-0390-x
   PubMed Web of Science ®Google Scholar
• Ferguson KK, Loch-Caruso R, Meeker JD. Exploration of oxidative stress and inflammatory markers in relation to urinary phthalate metabolites: NHANES 1999–2006. Environ Sci Technol 2012;46(1):477–85. doi: 10.1021/es202340b
   PubMed Web of Science ®Google Scholar
• Ferguson KK, McElrath TF, Meeker JD. Environmental phthalate exposure and preterm birth. JAMA Pediatr 2014;168(1):61–7. doi: 10.1001/jamapediatrics.2013.3699
   PubMed Web of Science ®Google Scholar
• Ota E, Mori R, Middleton P, Tobe-Gai R, Mahomed K, Miyazaki C, et al. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev 2015;2:CD000230.
   PubMed Web of Science ®Google Scholar
• Stein TP, Schluter MD, Steer RA, Guo L, Ming X. Bisphenol A exposure in children with autism spectrum disorders. Autism Res 2015;8(3):272–83. doi: 10.1002/aur.1444
   PubMed Web of Science ®Google Scholar
• Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KN, et al. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 2011;128(5):873–82. doi: 10.1542/peds.2011-1335
   PubMed Web of Science ®Google Scholar
• Braun JM, Yolton K, Dietrich KN, Hornung R, Ye X, Calafat AM, et al. Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect 2009;117(12):1945–52. doi: 10.1289/ehp.0900979
   PubMed Web of Science ®Google Scholar
• Perera F, Vishnevetsky J, Herbstman JB, Calafat AM, Xiong W, Rauh V, et al. Prenatal bisphenol A exposure and child behavior in an inner-city cohort. Environ Health Perspect 2012;120(8):1190–4. doi: 10.1289/ehp.1104492
   PubMed Web of Science ®Google Scholar
• Smith CA, Macdonald A, Holahan MR. Acute postnatal exposure to di(2-ethylhexyl) phthalate adversely impacts hippocampal development in the male rat. Neuroscience 2011;193:100–8. doi: 10.1016/j.neuroscience.2011.06.082
   PubMed Web of Science ®Google Scholar
• Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci USA 2013;110(24):9956–61. doi: 10.1073/pnas.1214056110
   PubMed Web of Science ®Google Scholar
• Carbone S, Ponzo OJ, Gobetto N, Samaniego YA, Reynoso R, Scacchi P, et al. Antiandrogenic effect of perinatal exposure to the endocrine disruptor di-(2-ethylhexyl) phthalate increases anxiety-like behavior in male rats during sexual maturation. Horm Behav 2013;63(5):692–9. doi: 10.1016/j.yhbeh.2013.01.006
   PubMed Web of Science ®Google Scholar
• Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007;104(32):13056–61. doi: 10.1073/pnas.0703739104
   PubMed Web of Science ®Google Scholar
• Erden ES, Motor S, Ustun I, Demirkose M, Yuksel R, Okur R, et al. Investigation of bisphenol A as an endocrine disruptor, total thiol, malondialdehyde, and C-reactive protein levels in chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 2014;18(22):3477–83.
   PubMed Web of Science ®Google Scholar
• Yang YJ, Hong YC, Oh SY, Park MS, Kim H, Leem JH, et al. Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environ Res 2009;109(6):797–801. doi: 10.1016/j.envres.2009.04.014
   PubMed Web of Science ®Google Scholar
• Watkins DJ, Ferguson KK, Anzalota Del Toro LV, Alshawabkeh AN, Cordero JF, Meeker JD. Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico. Int J Hyg Environ Health 2015;218(2):212–9. doi: 10.1016/j.ijheh.2014.11.001
   PubMed Web of Science ®Google Scholar
• Lipinski RJ, Hammond P, O'Leary-Moore SK, Ament JJ, Pecevich SJ, Jiang Y, et al. Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependent. PloS One 2012;7(8):e43067. doi: 10.1371/journal.pone.0043067
   PubMed Web of Science ®Google Scholar
• Mattson SN, Crocker N, Nguyen TT. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychol Rev 2011;21(2):81–101. doi: 10.1007/s11065-011-9167-9
   PubMed Web of Science ®Google Scholar
• Wheeler SM, Stevens SA, Sheard ED, Rovet JF. Facial memory deficits in children with fetal alcohol spectrum disorders. Child Neuropsychol 2012;18(4):339–46.
   PubMed Web of Science ®Google Scholar
• Coles CD, Kable JA, Keen CL, Jones KL, Wertelecki W, Granovska IV, et al. Dose and timing of prenatal alcohol exposure and maternal nutritional supplements: developmental effects on 6-month-old infants. Matern Child Health J 2015. doi: 10.1007/s10995-015-1779-x.
   PubMed Web of Science ®Google Scholar
• Carey LC, Coyle P, Philcox JC, Rofe AM. Maternal ethanol exposure is associated with decreased plasma zinc and increased fetal abnormalities in normal but not metallothionein-null mice. Alcohol Clin Exp Res 2000;24(2):213–9. doi: 10.1111/j.1530-0277.2000.tb04593.x
   PubMed Web of Science ®Google Scholar
• Serrano M, Han M, Brinez P, Linask KK. Fetal alcohol syndrome: cardiac birth defects in mice and prevention with folate. Am J Obstetr Gynecol 2010;203(1):75.e7–15. doi: 10.1016/j.ajog.2010.03.017
   PubMed Web of Science ®Google Scholar
• Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006;368(9553):2167–78. doi: 10.1016/S0140-6736(06)69665-7
   PubMed Web of Science ®Google Scholar
• Landrigan PJ. The worldwide problem of lead in petrol. Bull World Health Organ 2002;80(10):768.
   PubMed Web of Science ®Google Scholar
• Selin NE. Science and strategies to reduce mercury risks: a critical review. J Environ Monit 2011;13(9):2389–99. doi: 10.1039/c1em10448a
   PubMed Web of Science ®Google Scholar
• Min KB, Lee KJ, Park JB, Min JY. Lead and cadmium levels and balance and vestibular dysfunction among adult participants in the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Environ Health Perspect 2012;120(3):413–7. doi: 10.1289/ehp.1103643
   PubMed Web of Science ®Google Scholar
• Kessler R. Lead-based decorative paints: where are they still sold-and why? Environ Health Perspect 2014;122(4):A96–A103. doi: 10.1289/ehp.122-a96
   PubMed Web of Science ®Google Scholar
• Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987;316(17):1037–43. doi: 10.1056/NEJM198704233161701
   PubMed Web of Science ®Google Scholar
• Liu J, Gao D, Chen Y, Jing J, Hu Q, Chen Y. Lead exposure at each stage of pregnancy and neurobehavioral development of neonates. Neurotoxicology 2014;44:1–7. doi: 10.1016/j.neuro.2014.03.003
   PubMed Web of Science ®Google Scholar
• Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, et al. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. Environ Health Perspect 2013;121(8):978–84.
   PubMed Web of Science ®Google Scholar
• Geier DA, Kern JK, Geier MR. A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. Acta Neurobiol Exp (Wars) 2009;69(2):189–97.
   PubMed Web of Science ®Google Scholar
• Yiangou M, Ge X, Carter KC, Papaconstantinou J. Induction of several acute-phase protein genes by heavy metals: a new class of metal-responsive genes. Biochemistry 1991;30(15):3798–806. doi: 10.1021/bi00229a029
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Kuroda J, Shibata N, Hasegawa T, Seko Y, Satoh M, et al. Induction of metallothionein by manganese is completely dependent on interleukin-6 production. J Pharmacol Exp Ther 2007;320(2):721–7. doi: 10.1124/jpet.106.112912
   PubMed Web of Science ®Google Scholar
• Cerklewski FL. Influence of dietary zinc on lead toxicity during gestation and lactation in the female rat. J Nutr 1979;109(10):1703–9.
   PubMed Web of Science ®Google Scholar
• Wolf AW, Jimenez E, Lozoff B. Effects of iron therapy on infant blood lead levels. J Pediatr 2003;143(6):789–95. doi: 10.1067/S0022-3476(03)00540-7
   PubMed Web of Science ®Google Scholar
• Rico JA, Kordas K, Lopez P, Rosado JL, Vargas GG, Ronquillo D, et al. Efficacy of iron and/or zinc supplementation on cognitive performance of lead-exposed Mexican schoolchildren: a randomized, placebo-controlled trial. Pediatrics 2006;117(3):e518–27. doi: 10.1542/peds.2005-1172
   PubMed Web of Science ®Google Scholar
• Solon O, Riddell TJ, Quimbo SA, Butrick E, Aylward GP, Lou Bacate M, et al. Associations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines. J Pediatr 2008;152(2):237–43. doi: 10.1016/j.jpeds.2007.09.008
   PubMed Web of Science ®Google Scholar